Compliance Rate

Compliance Rate 100.0%
Compliant submissions 2
Incompliant submissions 0
Total trials 2

My Organizations' Clinical Trials

Showing 175 of 910 entries
View as:

Testing a Positive Psychology-based Intervention for Couples Coping With Stroke

Phase: N/A Priority: Normal
NCT ID: NCT03335358 Org: User:
Start: 04/14/17 End: 03/31/20 Due: 03/31/21

Neutrophil Extracellular Trap Formation in Patients Undergoing Bone Marrow Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01735565 Org: User:
Start: 06/30/12 End: 07/31/16 Due: 07/31/17

Sun Protection and Tanning Awareness in Rural Schools

Phase: N/A Priority: Normal
NCT ID: NCT06694571 Org: User:
Start: 10/14/24 End: 07/31/25 Due: 07/31/26

[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03276676 Org: User:
Start: 09/24/18 End: 08/18/23 Due: 08/18/24

Metformin and Muscle Recovery

Phase: N/A Priority: Normal
NCT ID: NCT06185179 Org: User:
Start: 09/01/24 End: 05/31/30 Due: 05/31/31

Efficacy of Transfer Factor to Prevent Upper Respiratory Tract Infections in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01106183 Org: User:
Start: 01/31/10 End: 03/31/10 Due: 03/31/11

Reach Through Equitable Implementation in Utah

Phase: N/A Priority: Normal
NCT ID: NCT06881069 Org: User:
Start: 02/13/25 End: 01/30/28 Due: 01/30/29

Pimecrolimus Cream for Oral Lichen Planus

Phase: N/A Priority: Normal
NCT ID: NCT00297037 Org: User:
Start: 08/31/05 End: 02/28/09 Due: 02/28/10

Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial)

Phase: N/A Priority: Normal
NCT ID: NCT04772222 Org: User:
Start: 06/20/22 End: 12/31/25 Due: 12/31/26

Protein Supplementation in Dialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01855295 Org: User:
Start: 11/30/09 End: 08/31/12 Due: 08/31/13

Effects of Behavioral Interventions on Mechanisms of Pain Regulation and Hedonic Regulation

Phase: N/A Priority: Normal
NCT ID: NCT02935465 Org: User:
Start: 09/30/16 End: 06/30/19 Due: 06/30/20

Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01090128 Org: User:
Start: 09/30/08 End: 03/24/17 Due: 03/24/18

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia (CLL) With History of Non-melanoma Skin Cancers (NMSC)

Phase: N/A Priority: Normal
NCT ID: NCT04844528 Org: User:
Start: 08/05/21 End: 08/01/27 Due: 08/01/28

Anterior Tibiotalar Arthrodesis With Blade Plate Fixation

Phase: N/A Priority: Normal
NCT ID: NCT01818466 Org: User:
Start: 11/30/12 End: 05/31/16 Due: 05/31/17

Promoting Resilience in Stroke Survivor-carepartner Dyads (ReStoreD)

Phase: N/A Priority: Normal
NCT ID: NCT04845542 Org: User:
Start: 07/20/22 End: 08/31/27 Due: 08/31/28

Improving Patient and Family Health Using Family-Centered Outcomes and Shared Decision-Making

Phase: N/A Priority: Normal
NCT ID: NCT04437069 Org: User:
Start: 10/01/20 End: 06/30/25 Due: 06/30/26

Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03827473 Org: User:
Start: 02/08/19 End: 07/31/19 Due: 07/31/20

Pediatric Cervical Spine Clearance: A Multicenter Prospective Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT05608460 Org: User:
Start: 08/15/22 End: 08/15/25 Due: 08/15/26

Effects of Clear Speech on Listening Effort and Memory in Sentence Processing

Phase: N/A Priority: Normal
NCT ID: NCT06053190 Org: User:
Start: 09/12/23 End: 03/01/25 Due: 03/01/26

Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study

Phase: N/A Priority: Normal
NCT ID: NCT01475747 Org: User:
Start: 09/30/11 End: 12/31/18 Due: 12/31/19

The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis

Phase: N/A Priority: Normal
NCT ID: NCT04372615 Org: User:
Start: 03/30/22 End: 08/31/26 Due: 08/31/27

Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna

Phase: N/A Priority: Normal
NCT ID: NCT00707174 Org: User:
Start: 03/31/05 End: 03/31/13 Due: 03/31/14

Electronic Pharmacotherapy Risk Management

Phase: N/A Priority: Normal
NCT ID: NCT00828490 Org: User:
Start: 07/31/07 End: 03/31/10 Due: 03/31/11

High-Resolution Diffusion Tensor Imaging (DTI) of the Cervical Spinal Cord in the Setting of Spinal Cord Injury (SCI)

Phase: N/A Priority: Normal
NCT ID: NCT01407705 Org: User:
Start: 05/31/07 End: 05/31/14 Due: 05/31/15

Improving Decision Role Concordance in Newly Diagnosed Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03350854 Org: User:
Start: 03/07/16 End: 08/09/17 Due: 08/09/18